DWP422
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DWP422, covering 2012-07-26 to 2012-07-26. Get the full timeline:
Most recent: Clinical Trial Update: Comparison the Safety and Pharmacokinetic Characteristics of DWP422 25 mg With Those of ENBREL 25MG PFS INJ. After Subcutaneous Injection in Healthy Male Volunteers [Phase 1]